4//SEC Filing
Connaughton Bernadette 4
Accession 0001159036-25-000052
CIK 0001159036other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:58 PM ET
Size
4.9 KB
Accession
0001159036-25-000052
Insider Transaction Report
Form 4
Connaughton Bernadette
Director
Transactions
- Sale
Common Stock
2025-11-10$68.48/sh−2,000$136,960→ 42,952 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001662521
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:58 PM ET
- Size
- 4.9 KB